Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 233 results for "clinigene"

Clinigen expands specialty pharma portfolio with SAVENE acquisition
Proactive Investors.co.uk

Clinigen acquires Savene from SpePharm AG

Specialty global pharmaceutical company, Clinigen Group has acquired Savene (dexrazoxane) from SpePharm AG, a majority owned affiliate of Norgine BV. The financial terms of the acquisition are not being disclosed. Savene is indicated for the ... PharmaBiz, 2 weeks ago
Clinigen gains rights to SpePharm's Savene Pharma Letter, 2 weeks ago
Clinigen expands with acquisition of Savene Insider Media Limited, 2 weeks ago

19 images for clinigene

Proactive Investors.co.uk, 4 days ago
Proactive Investors.co.uk, 4 days ago
zolmax.com, 2 weeks ago
Proactive Investors.co.uk, 2 weeks ago
Building Products UK, 2 weeks ago
Proactive Investors.co.uk, 3 weeks ago
Pharma Letter, 1 month ago
Proactive Investors.co.uk, 1 month ago
Mideast Time, 1 month ago
Zolmax News, 1 month ago

Clinigen Group PLC announces interim dividend

7:00am GMT Clinigen Group PLC:To pay an interim dividend of 1.0 pence per share (H1FY13: 0.6 pence).Payment date March 28.Record
 Reuters UK1 month ago
Proactive Investors.co.uk

Clinigen Group to Manage International Named Patient Program for Abiogen Pharma's Nerixia® (Neridronic Acid)

PR.com 2014-04-16 Burton-on-Trent, United Kingdom, April 16, 2014 --( PR.com )-- Clinigen Group plc (Clinigen or the Group) (AIM: CLIN) and Abiogen Pharma SpA (Abiogen) jointly announced today the initiation of a Named Patient Program, managed by ...
 BizWire Express2 days ago Clinigen deal falls flat  Shares Magazine4 days ago CLINIGEN : To Provide Abiogen Pharma's Nerixia Through Named Patient Programme  4 Traders4 days ago Clinigen to manage named patient program for Abiogen Pharma's Nerixia®  Noodls4 days ago
[x]  

Clinigen : Agrees New 4-Year GBP35 Million Debt Facility With RBS

LONDON ( Alliance News ) - Clinigen Group PLC Friday said it has secured a new four year GBP35 million multi-currency revolving credit facility, with the option for a GBP15 million top-up. The specialty pharmaceuticals company said the new ...
 4 Traders2 weeks ago Clinigen Group agrees new credit facility with RBS  BullBearings2 weeks ago
[x]  

FLASH: Numis lifts Clinigen Group to buy from hold, target raised from 620p to 650p

StockMarketWire.com - Story provided
 Stock Market Wire2 weeks ago Numis lifts Clinigen Group to buy from hold, target raised from 620p to 650p  MoneyAM2 weeks ago Numis cuts Clinigen Group to hold from buy, target raised from 485p to 620p  MoneyAM1 month ago FLASH: Numis cuts Clinigen Group to...  This is Money1 month ago

Clinigen gains approval to re-launch Telavancin pneumonia drug

Clinigen Group said Tuesday that the European Commission (EC) had agreed to lift the Europe-wide suspension of marketing authorisation for Vibativ, its Telavancin treatment used to treat hospital-acquired pneumonia. The group said it consequently ...
 BullBearings1 month ago
[x]  

Clinigen interim profits up, but shares fall sharply on broker downgrade

Pharmaceuticals company Clinigen reported first half pre-tax profits of 9.6m pounds, up from 3.7m in 2012, but shares in the company were marked down sharply after a broker downgrade. Underlying earnings before interest, tax, depreciation and ...
 London South East1 month ago Clinigen profits jump in first half  Insider Media Limited1 month ago
[x]  
Proactive Investors.co.uk

Market movers: Glencore, Amphion, Clinigen, Iofina, Ortac, Richland, StratMin, W Resources

The market has opened lower, as expected, as investors fret over rising tensions in Ukraine. Fallers outnumber risers by more than five to one among FTSE 100 constituents, with mining groups Glencore (), Randgold (), () and Antofagasta () among ...
 Proactive Investors.co.uk4 days ago

Clinigen's growth drive

Debt package sets firm up to buy niche revenue-generating products Investors should use a wobble in specialty pharmaceuticals and services business Clinigen (CLIN:AIM) as an entry opportunity. Following last week's news (4 Apr) of a new £35 ...
 Shares Magazine1 week ago

Clinigen agrees new £35m ban...

Clinigen Group has agreed a new four year £35m multi-currency revolving credit facility. An accordion option has also been agreed under which Clinigen can request an additional £15m on the same terms. The facility has been provided by the ...
 TrustNet2 weeks ago FLASH: Clinigen agrees new £35m banking facility  Stock Market Wire2 weeks ago Clinigen agrees new £35m banking facility  Insider Media Limited2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less